© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
The Cleveland Clinic Foundation
Latest from The Cleveland Clinic Foundation
Ways to Lower Genetic Leukodystrophies Misdiagnosis in Clinical Settings: Alise Carlson, MD
April 06, 2021
Video
Alise Carlson, MD, a resident at Cleveland Clinic, provided insight on how raising awareness for genetic leukodystrophies may ultimately improve misdiagnosis rates.
Lenalidomide’s Outlook as Future Alzheimer DMT: Marwan Sabbagh, MD
April 01, 2021
Video
The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed whether lenalidomide, a repurposed cancer drug, has promise as an Alzheimer disease DMT.
Understanding the Complex Diagnosis of Genetic Leukodystrophies: Alise Carlson, MD
March 27, 2021
Video
Alise Carlson, MD, a resident at Cleveland Clinic, detailed the reasons for her study evaluating genetic leukodystrophies and their differences to multiple sclerosis at diagnosis.
The COVID Focus and the Top Talks at ACTRIMS 2021: Jeffrey Cohen, MD
March 22, 2021
Video
The president of the Americas Committee for Treatment and Research in MS shared his perspective on the impact of COVID and the top talks at the ACTRIMS Forum 2021.
Forced Exercise Shows Improvement in Poststroke Lower Extremity Motor Function
March 18, 2021
Article
The findings suggest the externally altered proprioceptive feedback in forced exercises may be increasing cortical engagement.
Identifying and Diagnosing Genetic Leukodystrophies as MS Mimics
March 16, 2021
Article
Alise Carlson, MD, a resident at Cleveland Clinic, discussed her presentation from ACTRIMS Forum 2021 on the misdiagnosis of adult-onset genetic leukodystrophies as multiple sclerosis.